{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:30:02Z","timestamp":1786321802310,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd001939.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000}}],"reference-count":167,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001939.pub5","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:40:22Z","timestamp":1768570822000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-887X","authenticated-orcid":false,"given":"Luise","family":"Aamann","sequence":"additional","affiliation":[{"name":"The Gastro Unit, Medical Division; Copenhagen University Hospital Hvidovre; Hvidovre Denmark"},{"name":"Department of Digestive Diseases, Transplantation and General Surgery - Section for Liver Diseases; Copenhagen University Hospital Rigshospitalet; Copenhagen Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Deshpande","sequence":"additional","affiliation":[{"name":"University College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-0171","authenticated-orcid":false,"given":"Gitte","family":"Dam","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2769-0676","authenticated-orcid":false,"given":"I\u00f1igo","family":"Les","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Navarra; Pamplona (Navarra) Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-9860","authenticated-orcid":false,"given":"Giulio","family":"Marchesini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Alma Mater Studiorum; University of Bologna; Bologna Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3834-383X","authenticated-orcid":false,"given":"Mette","family":"Borre","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1524-8952","authenticated-orcid":false,"given":"Niels Kristian","family":"Aagaard","sequence":"additional","affiliation":[{"name":"Department of Hepatology and Gastroenterology; Aarhus University Hospital; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Vilstrup","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Hepatology and Gastroenterology; Aarhus University; Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9462-4468","authenticated-orcid":false,"given":"Lise Lotte","family":"Gluud","sequence":"additional","affiliation":[{"name":"The Gastro Unit, Medical Division; Copenhagen University Hospital Hvidovre; Hvidovre Denmark"},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"issue":"10308","key":"10.1002\/14651858.CD001939.pub5-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1478-3231.2009.02030.x","article-title":"Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Guerit","year":"2009","journal-title":"Liver International"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","article-title":"Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Randolph","year":"2009","journal-title":"Liver International"},{"issue":"7","key":"10.1002\/14651858.CD001939.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy - an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"American Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","article-title":"Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy","volume":"73","author":"Rose","year":"2020","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","author":"Montagnese","year":"2022","journal-title":"Journal of Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jhep.2008.04.022","article-title":"Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study","volume":"49","author":"Amodio","year":"2008","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jcrc.2009.01.008","article-title":"Prognosis and 1-year mortality of intensive care unit patients with severe hepatic encephalopathy","volume":"24","author":"Fichet","year":"2009","journal-title":"Journal of Critical Care"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis","volume":"3","author":"Muto","year":"2005","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"issue":"23","key":"10.1002\/14651858.CD001939.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.14.3609","article-title":"Minimal encephalopathy matters in daily life","volume":"14","author":"Bajaj","year":"2008","journal-title":"World Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nut.2009.06.027","article-title":"Three targets of branched-chain amino acid supplementation in the treatment of liver disease","volume":"26","author":"Holecek","year":"2010","journal-title":"Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD001939.pub5-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","article-title":"ESPEN practical guideline: clinical nutrition in liver disease","volume":"30","author":"Bischoff","year":"2020","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ajg.2011.9","article-title":"Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study","volume":"106","author":"Les","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0018|cit18","first-page":"448","article-title":"Dietary management of hepatic encephalopathy revisited","volume":"17","author":"Amodio","year":"2014","journal-title":"Current Opinion in Clinical Nutrition and Metabolic Care"},{"issue":"8","key":"10.1002\/14651858.CD001939.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10620-014-3086-6","article-title":"Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis","volume":"59","author":"Roman","year":"2014","journal-title":"Digestive Diseases and Sciences"},{"issue":"1","key":"10.1002\/14651858.CD001939.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11011-013-9428-9","article-title":"Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy \u2014therapeutic perspectives","volume":"29","author":"Holecek","year":"2014","journal-title":"Metabolic Brain Disease"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jhep.2018.03.027","article-title":"Ammonia: this is not the end but rather the end of the beginning","volume":"68","author":"Weiss","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bpg.2006.07.009","article-title":"Management of hepatic encephalopathy in patients with cirrhosis","volume":"21","author":"Wright","year":"2007","journal-title":"Best Practice & Research Clinical Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MCC.0b013e328344b37e","article-title":"Acute-on-chronic liver failure: the brain","volume":"17","author":"Garc\u00eda-Mart\u00ednez","year":"2011","journal-title":"Current Opinion in Critical Care"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00726-010-0679-z","article-title":"Acute hyperammonemia activates branched-chain amino acid catabolism and decreases their extracellular concentrations: different sensitivity of red and white muscle","volume":"40","author":"Holecek","year":"2011","journal-title":"Amino Acids"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"G269","DOI":"10.1152\/ajpgi.00062.2011","article-title":"Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects","volume":"301","author":"Dam","year":"2011","journal-title":"American Journal of Physiology. Gastrointestinal and Liver Physiology"},{"issue":"10","key":"10.1002\/14651858.CD001939.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.nut.2013.01.022","article-title":"Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications","volume":"29","author":"Holecek","year":"2013","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"C\u00f3rdoba","year":"2004","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MOG.0b013e3283409c25","article-title":"Diet and cognition in chronic liver disease","volume":"27","author":"Kachaamy","year":"2011","journal-title":"Current Opinion Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1053\/jhep.2002.36497","article-title":"Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS","volume":"36","author":"Olde Damink","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jhep.2016.06.004","article-title":"Metabolic adaptation of skeletal muscle to hyperammonemia drives the beneficial effects of L-leucine in cirrhosis","volume":"65","author":"Davuluri","year":"2016","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/hep.27717","article-title":"Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis","volume":"61","author":"Tsien","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/0884533613496432","article-title":"Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis","volume":"28","author":"Kawaguchi","year":"2013","journal-title":"Nutrition in Clinical Practice"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"950","DOI":"10.14309\/ajg.0000000000003379","article-title":"ACG Clinical Guideline: malnutrition and nutritional recommendations in liver disease","volume":"120","author":"Singal","year":"2025","journal-title":"American Journal of Gastroenterology"},{"issue":"1","key":"10.1002\/14651858.CD001939.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/hep.24616","article-title":"Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study","volume":"55","author":"Rakoski","year":"2012","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0016-5085(85)80004-4","article-title":"Branched chain amino acids in the treatment of latent portosystemic encephalopathy. A double-blind placebo-controlled crossover study","volume":"88","author":"Egberts","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0168-8278(90)90278-Y","article-title":"Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein controlled trial. The Italian Multicenter Study Group","volume":"11","author":"Marchesini","year":"1990","journal-title":"Journal of Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2009.04211.x","article-title":"Review article: the modern management of hepatic encephalopathy","volume":"31","author":"Bajaj","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases","volume":"61","author":"American Association for the Study of Liver Diseases","year":"2014","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0040|cit40","first-page":"11","volume-title":"Advances in Hepatic Encephalopathy and Urea Cycle Diseases","author":"Tygstrup","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0016-5085(89)91517-5","article-title":"Parenteral nutrition with branched-amino acids in hepatic encephalopathy. A meta-analysis","volume":"97","author":"Naylor","year":"1989","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD001939.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/hep.1840130438","article-title":"Branched-chain amino acids for hepatic encephalopathy?","volume":"13","author":"Gluud","year":"1991","journal-title":"Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD001939.pub5-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939","article-title":"Branched-chain amino acids for hepatic encephalopathy","author":"Als-Nielsen","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.clnu.2014.02.011","article-title":"Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review","volume":"33","author":"Metcalfe","year":"2014","journal-title":"Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939.pub2","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD001939.pub5-BIB0046|cit46","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001939.pub3","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","author":"Gluud","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/14651858.CD001939.pub4","article-title":"Branched-chain amino acids for people with hepatic encephalopathy","volume":"5","author":"Gluud","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3945\/jn.113.174375","article-title":"Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials","volume":"143","author":"Gluud","year":"2013","journal-title":"Journal of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11011-012-9372-0","article-title":"Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?","volume":"28","author":"Gluud","year":"2013","journal-title":"Metabolic Brain Disease"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jceh.2023.05.015","article-title":"Intravenous BCAA infusion does not lead to a sustained recovery from overt HE in ACLF \u2013 an open label randomized clinical trial","volume":"13","author":"Mehtani","year":"2023","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"8","key":"10.1002\/14651858.CD001939.pub5-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.3390\/nu11081810","article-title":"Supplementation with synbiotics and\/or branched chain amino acids in hepatic encephalopathy: a pilot randomised placebo-controlled clinical study","volume":"11","author":"Vidot","year":"2019","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0052|cit52","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0053|cit53","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"issue":"1","key":"10.1002\/14651858.CD001939.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0055|cit55","unstructured":"International Council for Harmonisation of technical requirements for pharmaceuticals for human use (ICH) ICH Harmonised Guideline. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2) database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0056|cit56","first-page":"0901","article-title":"Diarrhoea in adults (acute)","volume":"2011","author":"Gottlieb","year":"2011","journal-title":"BMJ Clinical Evidence"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0057|cit57","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies (last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0058|cit58","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5.1 Cochrane, 2025 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0060|cit60","first-page":"n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0061|cit61","unstructured":"Higgins JP Sterne JA Savovi\u0107 J Page MJ Hr\u00f3bjartsson A Boutron I A revised tool for assessing risk of bias in randomized trials Cochrane Database of Systematic Reviews 2016 10 Suppl 1 29 31 dx.doi.org\/10.1002\/14651858.CD201601"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0062|cit62","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0063|cit63","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0064|cit64","unstructured":"Higgins JP Savovi\u0107 J Page MJ Sterne JA; on behalf of the RoB2 Development Group Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) www.riskofbias.info\/welcome\/rob-2-0-tool\/current-version-of-rob-2"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0065|cit65","unstructured":"Higgins JP Li T Sterne J; on behalf of the RoB 2 working group on crossover trials Revised Cochrane risk of bias tool for randomized trials (RoB 2). Additional considerations for crossover trials (preliminary tool version, 18 March 2021) www.riskofbias.info\/welcome\/rob-2-0-tool\/rob-2-for-crossover-trials"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0066|cit66","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Chapter 10: Analysing data and undertaking meta-analyses [last updated November 2024]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0067|cit67","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Chapter 9: Summarizing study characteristics and preparing for synthesis [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0068|cit68","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0069|cit69","unstructured":"Peryer G Golder S Junqueira D Vohra S Loke YK Chapter 19: Adverse effects [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0070|cit70","unstructured":"Higgins JP Li T Chapter 6: Choosing effect measures and computing estimates of effect [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0071|cit71","unstructured":"Higgins JP Eldridge S Chapter 23: Including variants on randomized trials [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0072|cit72","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis [last updated August 2023]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD001939.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/sim.4088","article-title":"Sequential methods for random-effects meta-analysis","volume":"30","author":"Higgins","year":"2011","journal-title":"Statistics in Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD001939.pub5-BIB0074|cit74","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"20","key":"10.1002\/14651858.CD001939.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0076|cit76","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0077|cit77","unstructured":"Stata Statistical Software: Release 18 College Station, Stata Corp 2023"},{"issue":"7650","key":"10.1002\/14651858.CD001939.pub5-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0079|cit79","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach","volume":"150","author":"Zeng","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"e081904","DOI":"10.1136\/bmj-2024-081904","article-title":"GRADE 2: choosing the target of certainty rating and assessing imprecision","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD001939.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ygh2.439","article-title":"Quality of life indicators in hepatic encephalopathy following supplementation with branched chain amino acids and\/or synbiotics: a post-hoc analysis","volume":"3","author":"Perananthan","year":"2021","journal-title":"GastroHep"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001939.pub5-BIB0083|cit83","first-page":"38","article-title":"Patient-reported quality-of-life indicators in overt hepatic encephalopathy following supplementation with branched chain amino acids and\/or synbiotics: a post-hoc analysis","volume":"35","author":"Perananthan","year":"2020","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.14309\/01.ajg.0000582212.09652.6b","article-title":"Supplementation with synbiotics and\/or branched chain amino acids in hepatic encephalopathy","volume":"114","author":"Vidot","year":"2019","journal-title":"American Journal of Gastroenterology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001939.pub5-BIB0085|cit85","first-page":"S108","article-title":"Intravenous branched chain amino acid infusion is associated with early but ill-sustained recovery of overt hepatic encephalopathy in acute-on-chronic liver failure: a pilot protocol","volume":"76","author":"Mehtani","year":"2022","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jceh.2022.07.087","article-title":"Intravenous branched chain amino acid infusion is associated with early but ill-sustained recovery of overt hepatic encephalopathy in acute-on-chronic liver failure: a pilot protocol","volume":"12","author":"Mehtani","year":"2022","journal-title":"Journal of Clinical and Experimental Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001939.pub5-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1007\/s12664-021-01234-z","article-title":"Intravenous branched chain amino acids for the treatment of hepatic encephalopathy in acute-on-chronic liver failure - Interim analysis of the BCAA-ACLF trial","volume":"41","author":"Mehtani","year":"2022","journal-title":"Indian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(85)80762-5","article-title":"Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis","volume":"1","author":"Calvey","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0261-5614(84)80001-1","article-title":"Prospective study of nasogastric feeding via East Grinstead or Viomedex tubes compared with oral dietary supplementation in patients with cirrhosis","volume":"3","author":"Calvey","year":"1984","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0090|cit90","first-page":"361","volume-title":"Metabolism and Nutrition in Liver Disease","author":"Williams","year":"1985"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0148607185009003288","article-title":"Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial","volume":"9","author":"Cerra","year":"1985","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0092|cit92","unstructured":"Cerra FB Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial [personal communication] Correspondence with authors"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0093|cit93","first-page":"612","article-title":"Cirrhosis, encephalopathy, and improved results with metabolic support","volume":"94","author":"Cerra","year":"1983","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0094|cit94","first-page":"699","article-title":"A multicenter trial of branched chain enriched amino acid infusion (F080) in hepatic encephalopathy (HE)","volume":"2","author":"Cerra","year":"1982","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0095|cit95","first-page":"901","article-title":"Treatment with branched-chain amino acids and effect on psycho-physical capacity functions in latent porto-systemic encephalopathy","volume":"32","author":"Hamster","year":"1982","journal-title":"Arzneimittelforschung"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF02023616","article-title":"Branched-chain amino acids in the treatment of latent porto-systemic encephalopathy. A placebo-controlled double-blind cross-over study","volume":"25","author":"Egberts","year":"1986","journal-title":"Zeitschrift f\u00fcr Ern\u00e4hrungswissenschaft"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4684-4787-3_36","volume-title":"Hepatic Encephalopathy in Chronic Liver Failure","author":"Egberts","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0098|cit98","first-page":"5","article-title":"Effect of branched chain amino acids on latent porto-systemic-encephalopathy (PSE)","volume":"5","author":"Egberts","year":"1981","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0099|cit99","first-page":"5","article-title":"Branched chain amino acid enriched solutions in the treatment of hepatic encephalopathy: a controlled trial","volume":"17","author":"Fiaccadori","year":"1985","journal-title":"Italian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF02905351","article-title":"Selective amino acid solutions in hepatic encephalopathy treatment (a preliminary report)","volume":"10","author":"Fiaccadori","year":"1980","journal-title":"La Ricerca in Clinica e in Laboratorio"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/978-1-4684-4787-3_33","volume-title":"Hepatic Encephalopathy in Chronic Liver Failure","author":"Fiaccadori","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0102|cit102","first-page":"281","volume-title":"Metabolism and Nutrition in Liver Disease Freiburg 1984: Proceedings of the 41st Falk Symposium","author":"Fiaccadori","year":"1985"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0103|cit103","unstructured":"Fiaccadori F Branched chain amino acid enriched solutions in the treatment of hepatic encephalopathy: a controlled trial Italian Journal of Gastroenterology 1985;17:5-10."},{"key":"10.1002\/14651858.CD001939.pub5-BIB0104|cit104","first-page":"191","article-title":"A randomized controlled trial of branched-chain amino acid (BCAA)-enriched elemental diet (ED-H) for hepatic encephalopathy","volume":"6","author":"Hayashi","year":"1991","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.1840040218","article-title":"Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial","volume":"4","author":"Horst","year":"1984","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0106|cit106","first-page":"184","article-title":"A double-blind randomized comparison of dietary protein and an oral branched chain amino acid (BCAA) solution in cirrhotic patients with chronic portal-systemic encephalopathy (PSE) [IASL abstract]","volume":"2","author":"Horst","year":"1982","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0107|cit107","first-page":"185","article-title":"A randomized controlled trial for the evaluation of the efficacy of branched chain amino acid-enriched amino acid solution in the treatment of patients with hepatic encephalopathy","volume":"5","author":"Hwang","year":"1988","journal-title":"Chinese Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0109|cit109","first-page":"443","article-title":"Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels","volume":"39","author":"Bianchi","year":"1992","journal-title":"Hepato-gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1600-0676.1985.tb00250.x","article-title":"Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients","volume":"5","author":"Michel","year":"1985","journal-title":"Liver"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0111|cit111","first-page":"140","article-title":"Intravenous infusion of ordinary and modified amino-acid solutions in the management of hepatic encephalopathy","volume":"1","author":"Pomier-Layrargues","year":"1981","journal-title":"Liver"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0112|cit112","first-page":"1038","article-title":"Intravenous infusion of ordinary and modified amino-acid solutions in the management of hepatic encephalopathy (controlled study, 30 patients)","volume":"79","author":"Michel","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4684-4787-3_31","volume-title":"Hepatic Encephalopathy in Chronic Liver Failure","author":"Michel","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Horie-Takashi I Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis Clinical Gastroenterology and Hepatology 2005; 3:705-13.","DOI":"10.1016\/S1542-3565(05)00017-0"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.hepres.2005.01.009","article-title":"Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study)","volume":"31","author":"Sato","year":"2005","journal-title":"Hepatology Research"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0168-8278(05)80210-7","article-title":"Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-crossover study","volume":"17","author":"Plauth","year":"1993","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0117|cit117","first-page":"126","article-title":"Long-term treatment with branched-chain amino acids (BCA) improves the portosystemic encephalopathy (PSE) in ambulant patients. Results of a double blind, placebo controlled crossover study","volume":"69","author":"Plauth","year":"1992","journal-title":"Klinische Wochenschrift"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.27.Suppl_1.111","article-title":"Use of branched chain amino acids for treating hepatic encephalopathy: clinical experiences","volume":"27","author":"Rossi-Fanelli","year":"1986","journal-title":"Gut"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/BF01316578","article-title":"Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study","volume":"27","author":"Rossi-Fanelli","year":"1982","journal-title":"Digestive Diseases and Sciences"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-1-4684-4787-3_34","volume-title":"Hepatic Encephalopathy in Chronic Liver Failure","author":"Rossi-Fanelli","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4684-4787-3_18","volume-title":"Hepatic Encephalopathy in Chronic Liver Failure","author":"Riggio","year":"1984"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0122|cit122","first-page":"18","article-title":"Treatment of hepatic encephalopathy: a randomized clinical trial comparing a branched chain enriched amino acid solution to oral neomycin","volume":"6","author":"Strauss","year":"1986","journal-title":"Nutritional Support Services"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0123|cit123","first-page":"862","article-title":"A randomized controlled clinical trial for the evaluation of the efficacy of an enriched branched-chain amino-acid solution compared to neomycin in hepatic encephalopathy","volume":"3","author":"Strauss","year":"1983","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0168-8278(90)90135-E","article-title":"Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis","volume":"10","author":"Vilstrup","year":"1990","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"S347","DOI":"10.1016\/S0168-8278(85)80729-7","article-title":"Branched chain enriched amino acid nutrition does not change the outcome of hepatic coma in patients with cirrhosis of the liver","volume":"1","author":"Vilstrup","year":"1985","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0126|cit126","first-page":"19","article-title":"Preliminary treatment results with balanced amino acid infusion to patients with hepatic encephalopathy","volume":"18","author":"Gluud","year":"1983","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0127|cit127","unstructured":"Role of a type of amino acid in confusion related to liver diseases trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2019\/08\/020552"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0128|cit128","unstructured":"Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF) clinicaltrials.gov\/study\/NCT05700695?tab=results"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0129|cit129","unstructured":"BCAA vs. rifaximin in patients with cirrhosis for secondary prophylaxis of HE (HERB) clinicaltrials.gov\/study\/NCT06538077"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1177\/0148607185009006671","article-title":"Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis","volume":"9","author":"Christie","year":"1985","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.3390\/nu13113764","article-title":"Amino acid profile in malnourished patients with liver cirrhosis and its modification with oral nutritional supplements: implications on minimal hepatic encephalopathy","volume":"13","author":"Espina","year":"2021","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1872-034X.2007.00095.x","article-title":"Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis","volume":"37","author":"Hayashi","year":"2007","journal-title":"Hepatology Research"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MEG.0b013e328309c791","article-title":"Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study","volume":"21","author":"Malaguarnera","year":"2009","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/0148607187011005447","article-title":"Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease","volume":"11","author":"O'Keefe","year":"1987","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.nicl.2018.03.028","article-title":"Which of the branched-chain amino acids increases cerebral blood flow in hepatic encephalopathy? A double-blind randomized trial","volume":"19","author":"Romeiro","year":"2018","journal-title":"NeuroImage"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0136|cit136","doi-asserted-by":"publisher","first-page":"715795","DOI":"10.3389\/fnut.2021.715795","article-title":"Impact of branched chain amino acid on muscle mass, muscle strength, physical performance, combined survival, and maintenance of liver function changes in laboratory and prognostic markers on sarcopenic patients with liver cirrhosis (BCAAS Study): a randomized clinical trial","volume":"8","author":"Singh Tejavath","year":"2021","journal-title":"Frontiers in Nutrition"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0137|cit137","first-page":"105","article-title":"Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver. A double-blind crossover study","volume":"24","author":"Walker","year":"1982","journal-title":"Digestion"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/hepr.13486","article-title":"Outcomes of lactulose plus branched-chain amino acid infusion and lactulose alone for hepatic encephalopathy: a retrospective cohort study using a national inpatient database","volume":"50","author":"Okada","year":"2020","journal-title":"Hepatology Research"},{"issue":"4","key":"10.1002\/14651858.CD001939.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.jrn.2021.05.008","article-title":"Effect of branched-chain amino acid infusion on in-hospital mortality of patients with hepatic encephalopathy and end-stage kidney disease: a retrospective cohort study using a national inpatient database","volume":"32","author":"Okada","year":"2022","journal-title":"Journal of Renal Nutrition"},{"issue":"24","key":"10.1002\/14651858.CD001939.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"e6580","DOI":"10.1097\/MD.0000000000006580","article-title":"Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: a Korean nationwide, multicenter, retrospective, observational, cohort study","volume":"96","author":"Park","year":"2017","journal-title":"Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3390\/nu12051429","article-title":"Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study","volume":"12","author":"Park","year":"2020","journal-title":"Nutrients"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD001939.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1016\/S0618-8278(19)31334-9","article-title":"Effects of branched-chain amino acids on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study","volume":"70","author":"Park","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0143|cit143","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/BF02774169","article-title":"Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis","volume":"24","author":"Yoshida","year":"1989","journal-title":"Gastroenterologia Japonica"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0144|cit144","first-page":"482","article-title":"Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: a randomized, prospective trial","volume":"104","author":"Kanematsu","year":"1988","journal-title":"Surgery"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00535-007-2122-0","article-title":"Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus","volume":"43","author":"Kobayashi","year":"2008","journal-title":"Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nut.2016.07.013","article-title":"Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: a randomized trial","volume":"33","author":"Nojiri","year":"2017","journal-title":"Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD001939.pub5-BIB0147|cit147","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/lt.21758","article-title":"A randomized pilot trial of oral branched-chain amino acids in early cirrhosis: validation using prognostic markers for pre-liver transplant status","volume":"15","author":"Kawamura","year":"2009","journal-title":"Liver Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nut.2006.10.008","article-title":"BCAA-enriched snack improves nutritional state of cirrhosis","volume":"23","author":"Nakaya","year":"2007","journal-title":"Nutrition"},{"issue":"7","key":"10.1002\/14651858.CD001939.pub5-BIB0149|cit149","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1365-2036.2004.01920.x","article-title":"Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial","volume":"19","author":"Poon","year":"2004","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/gut.23.10.801","article-title":"Branched-chain amino acids in the treatment of chronic hepatic encephalopathy","volume":"23","author":"Eriksson","year":"1982","journal-title":"Gut"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.1840030402","article-title":"Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study","volume":"3","author":"Wahren","year":"1983","journal-title":"Hepatology"},{"issue":"7644","key":"10.1002\/14651858.CD001939.pub5-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ (Clinical Research Ed.)"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001939.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/ije\/dym001","article-title":"Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials","volume":"36","author":"Lathyris","year":"2007","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0155|cit155","doi-asserted-by":"publisher","first-page":"497","DOI":"10.14309\/ajg.0000000000002472","article-title":"Cost of care for patients with Cirrhosis","volume":"119","author":"Kanwal","year":"2024","journal-title":"American Journal of Gastroenterology"},{"issue":"7","key":"10.1002\/14651858.CD001939.pub5-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jclinepi.2011.12.012","article-title":"Decisions about lumping vs. splitting of the scope of systematic reviews of complex interventions are not well justified: a case study in systematic reviews of health care professional reminders","volume":"65","author":"Weir","year":"2012","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001939.pub5-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1746-6342.2006.03216.x","article-title":"Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy","volume":"25","author":"Mullen","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2007.05.019","article-title":"Assessment of low-grade hepatic encephalopathy: a critical analysis","volume":"47","author":"Kircheis","year":"2007","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11011-012-9336-4","article-title":"Psychometric tests for diagnosing minimal hepatic encephalopathy","volume":"28","author":"Weissenborn","year":"2013","journal-title":"Metabolic Brain Disease"},{"key":"10.1002\/14651858.CD001939.pub5-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1740774508091600","article-title":"Imputation methods for missing outcome data in meta-analysis of clinical trials","volume":"5","author":"Higgins","year":"2008","journal-title":"Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD001939.pub5-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2036.2010.04418.x","article-title":"Meta-analysis: isosorbide-mononitrate alone or with either beta-blockers or endoscopic therapy for the management of oesophageal varices","volume":"32","author":"Gluud","year":"2010","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD001939.pub5-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008344.pub2","article-title":"Nutritional support for liver disease","author":"Koretz","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"30","key":"10.1002\/14651858.CD001939.pub5-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"10984","DOI":"10.12998\/wjcc.v10.i30.10984","article-title":"Branched-chain amino acids supplementation has beneficial effects on the progression of liver cirrhosis: a meta-analysis","volume":"10","author":"Du","year":"2022","journal-title":"World Journal of Clinical Cases"},{"issue":"3","key":"10.1002\/14651858.CD001939.pub5-BIB0165|cit165","doi-asserted-by":"publisher","first-page":"e13909","DOI":"10.1111\/eci.13909","article-title":"Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease","volume":"53","author":"Van Dijk","year":"2023","journal-title":"European Journal of Clinical Investigation"},{"issue":"6","key":"10.1002\/14651858.CD001939.pub5-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.clnu.2022.03.027","article-title":"Efficacy of branched chain amino acids supplementation in liver cirrhosis: a systematic review and meta-analysis","volume":"41","author":"Konstantis","year":"2022","journal-title":"Clinical Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD001939.pub5-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"e00542","DOI":"10.14309\/ctg.0000000000000542","article-title":"New evidence of oral branched-chain amino acid supplementation on the prognosis of patients with advanced liver disease","volume":"13","author":"Lee","year":"2022","journal-title":"Clinical and Translational Gastroenterology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:09:38Z","timestamp":1786320578000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD001939.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":167,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001939.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}